22 active not recruiting. 22 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 22 | Active not recruiting 22 |
| Phase 2 | 9 | Active not recruiting 9 |
Follow Arthritis: new trials by email Literature Review of Arthritis trials Research Report on Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 Diabetes Insulin Isophane Human, NPH, Pre-emptive Algorithm, Triamcinolone Acetonide Knee Injection - Diabetes Mellitus, Type 2, Hyperglycemia Due to Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | Active not recruiting | Shifa International Hospital | 125 | 2026-08-10 | 2026-09-15 |
| Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions SKI-O-703 API in Capsules, SKI-O-703 Formulated Granules in Capsules - Bioequivalence Study in Healthy Subjects, Immune Thrombocytopenia (ITP) | Phase 1 | Active not recruiting | Oscotec Inc. | 48 | 2026-07-10 | 2026-09-01 |
| Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR) Somatropin (recombinant human growth hormone), bacteriostatic saline placebo - Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA) | Phase 1 / Phase 2 | Active not recruiting | Dr. David Wasserstein | 34 | 2025-10-31 | 2026-07-31 |
| Oral Steroid Taper After Total Knee Arthroplasty Methylprednisolone - Osteoarthritis, Knee | Phase 1 | Active not recruiting | Columbia University | 116 | 2025-06-20 | 2026-04-20 |
| A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease Rapcabtagene autoleucel - Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD) | Phase 1 / Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 27 | 2025-06-20 | 2026-09-04 |
| An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis CND261 - Rheumatoid Arthritis | Phase 1 | Active not recruiting | Candid Therapeutics | 47 | 2025-06-16 | 2026-09-03 |
| An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis PIT565 - Rheumatoid Arthritis | Phase 1 | Active not recruiting | Novartis Pharmaceuticals | 57 | 2025-06-12 | 2026-06-30 |
| Study of GS-0151 in Participants With Rheumatoid Arthritis GS-0151, Placebo - Rheumatoid Arthritis | Phase 1 | Active not recruiting | Gilead Sciences | 65 | 2025-05-14 | 2026-09-03 |
| Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis ketoprofen - Knee Osteoarthritis | Phase 1 | Active not recruiting | New Valley University | 40 | 2025-05-10 | 2026-01-06 |
| Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis LPX-TI641, Placebo - Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) | Phase 1 | Active not recruiting | LAPIX Therapeutics Inc. | 48 | 2024-12-15 | 2026-10-30 |
| Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis KYV101, Rituximab (active comparator) - Rheumatoid Arthritis | Phase 1 / Phase 2 | Active not recruiting | Charite University, Berlin, Germany | 13 | 2024-12-04 | 2026-03-05 |
| Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L ANT-301 - Osteoarthritis, Knee | Phase 1 | Active not recruiting | Anterogen Co., Ltd. | 6 | 2024-10-22 | 2025-09-22 |
| Intra-articular Allocetra in Osteoarthritis of the 1st Carpo-metacarpal Joint Allocetra - Safety run-in phase, Placebo, Allocetra - Randomization phase - Osteoarthritis Thumb | Phase 1 / Phase 2 | Active not recruiting | Kaplan Medical Center | 46 | 2024-06-10 | 2026-04-13 |
| PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function SAP-001 - Gout, Hyperuricemia | Phase 1 / Phase 2 | Active not recruiting | Shanton Pharma Pte. Ltd. | 32 | 2024-04-24 | 2024-12-11 |
| Effectivity of Allogenic Umbilical Cord Mesenchymal Stem Cells Conditioned Media for Osteoarthritis of the Knee Joint Intra-articular secretome injection therapy - Osteoarthritis Knee | Phase 1 / Phase 2 | Active not recruiting | Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia | 11 | 2024-04-03 | 2024-11-15 |
| A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) CC-97540, Fludarabine, Cyclophosphamide - Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy | Phase 1 | Active not recruiting | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 270 | 2023-09-13 | 2026-08-03 |
| Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis GNSC-001, transient immune-modulation, Placebo - Osteoarthritis, Knee, Osteo Arthritis Knee | Phase 1 | Active not recruiting | Genascence Corporation | 67 | 2023-06-12 | 2025-08-01 |
| Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome tofacitinib, Placebo - Sjogren's Syndrome | Phase 1 / Phase 2 | Active not recruiting | National Institute of Dental and Craniofacial Research (NIDCR) | 23 | 2021-05-18 | 2025-12-18 |
| Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis hUC-MSC infusion (BC-U001) - Rheumatoid Arthritis | Phase 1 / Phase 2 | Active not recruiting | Beijing Baylx Biotech Co., Ltd. | 9 | 2021-04-12 | 2025-09-19 |
| Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee FX201 - Osteoarthritis, Knee | Phase 1 | Active not recruiting | Pacira Pharmaceuticals, Inc | 72 | 2020-03-02 | 2026-09-17 |
Showing 20 of 22. Sign in to see all of them.
Arthritis, Rheumatoid (9) · Osteoarthritis, Knee (8) · Osteoarthritis (2) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1) · Autoimmune Diseases (1) · Diabetes Mellitus, Type 2 (1) · Gout (1) · Hyperuricemia (1) · Inflammation (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Osteoarthritis, Hip (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Scleroderma, Systemic (1)
Joint Diseases (22) · Musculoskeletal Diseases (22) · Rheumatic Diseases (22) · Connective Tissue Diseases (11) · Immune System Diseases (11) · Skin and Connective Tissue Diseases (11) · Autoimmune Diseases (10) · Osteoarthritis (8) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Skin Diseases (2) · Arthritis, Rheumatoid (1)
Capsules (1) · Cyclophosphamide (1) · Growth Hormone (1) · Human Growth Hormone (1) · Insulin, Isophane (1) · Isophane Insulin, Human (1) · Ketoprofen (1) · Methylprednisolone (1) · Rituximab (1) · fludarabine (1) · tocilizumab (1) · tofacitinib (1) · upadacitinib (1)
Novartis Pharmaceuticals (2) · AbbVie (1) · Anterogen Co., Ltd. (1) · Beijing Baylx Biotech Co., Ltd. (1) · Candid Therapeutics (1) · Charite University, Berlin, Germany (1) · Columbia University (1) · Dr. David Wasserstein (1) · Genascence Corporation (1) · Gilead Sciences (1) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company (1) · Kaplan Medical Center (1) · Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia (1) · LAPIX Therapeutics Inc. (1) · Mayo Clinic (1)
United States (10) · Germany (6) · Spain (5) · France (3) · Canada (2) · China (2) · Hungary (2) · Israel (2) · Italy (2) · Moldova (2) · South Korea (2) · Argentina (1) · Belgium (1) · Bulgaria (1) · Egypt (1)
Aaron J Krych (1) · Bintang S Bintang Soetjahjo, MD, PhD (1) · Blake M Warner, D.D.S. (1) · David Simon, Professor Dr. med. (1) · Dr. David Wasserstein (1) · Jeymi Tambiah, MBChB (1) · Saima Abbass, MD, PhD (1) · Sara A Hassan (1) · Warren Rizzo, MD (1) · Xiaofeng Zeng, M.D., Ph.D. (1)
PMID 33229973, PMID 39284030, PMID 40826764, PMID 41607103, PMID 41638751, PMID 42661098
2023 (2)